BIOCHEMICAL IMPACT OF PHOSPHOLIPID-CONTAINING DRUGS ON LIVER DISEASES: A COMPREHENSIVE STUDY
Keywords:
Liver, cell membranes, fatty, phospholipids, antioxidant.Abstract
The biochemical insights into phospholipid-containing drugs provide a promising foundation for the development of novel therapies for liver diseases. Clinically, these drugs hold the potential to not only treat but also prevent the progression of liver conditions. Ongoing research focuses on optimizing drug formulations, dosage, and delivery methods to enhance their efficacy and reduce side effects.
References
The biochemical effects of phospholipid-containing drugs on liver diseases signify a significant stride in the realm of hepatology. By targeting fundamental cellular components and pathways, these drugs offer new hope for patients battling liver ailments. Continued research and clinical trials are essential to harness the full potential of phospholipid-based interventions, paving the way for improved treatments and ultimately, better outcomes for individuals affected by liver diseases.. – 2018. – Vol. 168, №14. – Р. 1568-1575.
Abduvaliev A.R., Inoyatova F.Kh., Mirkomilov E.M. A method of inhibiting t-helper 2 cells to prevent lung fibrosis that develops as a result of atypical pneumonia in COVID-19 // Proceeding of Global Congress of Contemporary Study- A Multidisciplinary International Scientific Conference Hosted from Pune, M.S. India.- P.182-187. www.econferenceglobe.com.
Sushentseva N. N., Popov O. S., Apalko S. V. et al. Biobank COVID-19: features of the cytokine profile / / Cardiovascular therapy and prevention. 2020, vol.19 (6), pp. 191-195..191-195.
Xia H., Bodempudi V., Benyumov A. et al. Identification of a celloforigin for fibroblasts comprising the fibrotic reticulum in idiopathic pulmonary fibrosis Am. J. Pathol. 2014;184: 1369–1383.
Maher T.M. Beyond the diagnosis of idiopathic pulmonary fibrosis: the growing role of systems biology and stratified medicine. Curr. Opin. Pulm. Med. 2013; 19: 460–465.
Thorax. The pulmonary physician in critical care 6: The pathogenesis of ALI/ARDS/ G.J.Bellingan // Thorax 2002 Jun; 57(6):540-6./ doi:10.1136/ thorax. 57.6.540.
Ниёзова, Ш. С., Турсунов, Д. Х., Алимов, С. М., Ахматова, К. А., & Султонова, Д. Ш. (2023). Covid-19 билан касалланган бeморлар қон зардобида оқсил алмашинуви кўрсаткичларининг тахлили (Doctoral dissertation, KLINIK LABORATOR DIAGNOSTIKADA INNOVATSION TEXNOLOGIYALARDAN FOYDALANISH, MUAMMOLAR VA YECHIMLAR).